Federal prime contract award
Recipient: MAPP BIOPHARMACEUTICAL, INC.
Awarding agency: Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response
Description: PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES
Award type: DEFINITIVE CONTRACT
Award amount: $220594030.58
Total outlays: $98077066.16
Period of performance: 2022-09-30 to 2030-09-30
NAICS: 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC: 6505 — DRUGS AND BIOLOGICALS
Place of performance (state): CA